“While it was heartening that the world spent $726 million on TB research in 2016, which was a small increase over previous years, at least $2 billion is needed annually to stay on track with the global goal of ending TB by 2030.” “This announcement is so important because better tools are urgently needed. Current methods of addressing TB mean we miss the global goal by 150 years. Globally, there were 10.4 million cases and 1.7 million deaths in 2016 while another 4.1 million people affected by TB are currently missed by health services,” adds Ms Nutt.
Can you name the world’s leading infectious disease killer? What is the infectious disease that kills the most people? It also surpassed HIV & AIDS in 2016 by killing 1.7 million people and making 10.4 million people sick. “The answer is tuberculosis (TB) which surprises most people. TB is a disease most Australians don’t even realise still exists but it affects more people than HIV and malaria.” says Maree Nutt, CEO of RESULTS Australia an anti-poverty non-profit that advocates on TB.
“While RESULTS welcomes a further contribution to GPE, Australia is becoming less generous with each replenishment. This pledge is a far cry from Australia’s four- year pledge of $270 million in 2011 which then dropped to $140 million from 2014. This new commitment also falls well short of the broad civil society campaign asking for $200 million, ”says Ms. Nutt.
International philanthropy supports Australian giving International philanthropy to Australia boosts the impact of domestic giving in alleviating hardship, gives voice to those who may otherwise be ignored, and contributes to a brighter future for many Australians. This is a time in which we should be working together to maximise international philanthropy in Australia, not restrict or ban it.
“I was delighted to represent RESULTS at the announcement of these initiatives in Brisbane on the weekend. Funding to expand research in the areas of tuberculosis and malaria treatment is much needed in Australia and the Pacific region which holds 60 per cent of the global burden.”
The Australian TB Caucus welcomes the call from G20 leaders on the weekend for a new platform to incentivise research and development to tackle drug-resistant infections – specifically in relation to the threat of tuberculosis (TB), which accounts for a third of deaths globally from drug resistance.
As the world’s leading infectious disease killer and the only airborne drug-resistant infection, TB is the nexus of the growing crisis of antimicrobial resistance (AMR), when organisms no longer respond to available drugs.
The World’s top tuberculosis official, UN Envoy Dr Eric Goosby, arrives in Australia today to highlight the urgent threat posed by multi-drug resistant tuberculosis on Australia’s doorstep, in southern Papua New Guinea.
“As the Budget contains some positive news about Australia’s economic growth and overall Budget outlook, it’s time we did more, not less. We must live up to our ‘fair go’ values and pull our weight to break the cycle of poverty and inequality.”